SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing high volatility as investors react to a significant stock offering intended to fund manufacturing expansion and operational growth. The community remains deeply divided, with bulls pointing to the company's role in the AI data center energy boom while bears express skepticism due to the company's historical challenges with dilution.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently at the center of a volatile semiconductor sector pullback, with market sentiment heavily pressured by broader concerns over AI valuation cycles and shifting geopolitical risks. While some investors are panic-selling and calling for deeper corrections, others see the current price action as an overreaction, pointing to institutional accumulation and strong long-term AI-driven fundamentals as reasons for a potential rebound.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense market volatility following the announcement of a 75-million-share public offering, which has sparked a heated debate between bulls who view the capital raise as a necessary step to fund factory expansion and satisfy government loan requirements, and bears who are frustrated by the immediate dilution and the timing of the news. The community is actively discussing the stock's future trajectory, with many retail investors expressing skepticism toward management's decision-making while traders look for potential support levels after a sharp price pullback.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing significant volatility following a patent infringement lawsuit from Wolfspeed, which has ignited intense debate among investors regarding potential legal overhang versus the company's long-term competitive position in the GaN and SiC markets. While some community members are bracing for further downside and questioning management's recent insider activity, others are treating the current pullback as a tactical buying opportunity, keeping a close watch on upcoming earnings for signs of sustained contract momentum.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy Inc. (TE) is currently experiencing intense volatility fueled by conflicting forces, including bullish sentiment surrounding its role in the AI-driven energy infrastructure stack and negative pressure from ongoing regulatory and short-seller scrutiny regarding its supply chain. The community is sharply divided between retail traders betting on a short squeeze or long-term growth and those skeptical of the company's financial health, with many actively monitoring Fibonacci levels and upcoming warrant expirations as critical catalysts for the stock's next move.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending as investors react to a strong quarterly earnings beat and raised guidance driven by record AI infrastructure and memory demand. The community is actively debating the company's valuation and long-term positioning as an AI factory partner, while traders closely monitor volatility and the high short interest surrounding the stock.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing intense investor activity and high-volume price fluctuations driven by persistent buyout rumors and strategic operational shifts, including the closure of its internal discovery facility. The community is actively debating the significance of these changes, with many investors weighing the potential for a strategic acquisition against concerns over long-standing stock manipulation and historical performance.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense volatility and trading activity as investors react to a recent reverse stock split proposal and ongoing questions regarding the company's mining operations. While some traders are speculating on a rebound fueled by Bitcoin's price movements, community sentiment remains deeply polarized between those betting on long-term infrastructure potential and others characterizing the stock as a speculative scam tied to political figures.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors digest a major $875.8 million acquisition of DZYNE Technologies, which significantly expands the company's autonomous defense portfolio and boosts 2026 revenue guidance to over $525 million. While management emphasizes the strategic scaling of its defense platform, community discourse remains sharply divided between those accumulating shares on dips due to long-term growth potential and others expressing frustration over continued share dilution.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is facing a sharp selloff driven by sector-wide rotation and concerns over potential AI infrastructure competition following reports of new cloud compute platforms. While some investors are actively calling this a warning sign or a bubble burst, others are viewing the pullback as a buying opportunity, emphasizing that Marvell's underlying fundamentals in the custom silicon and AI networking space remain resilient.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CAPR Stock Hits Over 4-Month Low: Capricor Execs Cash In $1.5M As FDA Sets Stage For DMD Drug Review 

Equity

Capricor is working toward a potential FDA decision by Aug. 22, making the next two months a key regulatory stretch for CAPR investors.

What's Going On With Capricor Therapeutics Stock On Friday?

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its Duchenne muscular dystrophy therapy.read more...

Capricor’s Positive 5-Year Data For DMD Treatment Comes With A Regulatory Catch – CAPR Stock Slides 11%

The U.S. Food and Drug Administration will hold an advisory committee meeting to review the biologics license application for Capricor’s DMD therapy on July 29

All Eyes On Capricor Therapeutics Ahead Of Crucial Hearing On DMD Therapy Agreement – CAPR Stock Jumps 6%

An oral argument on a dispute between Nippon Shinyaku, its U.S. subsidiary, NS Pharma, and Capricor is scheduled for Wednesday.

Capricor Therapeutics Q1 2026 Earnings Call Transcript

Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy

Capricor sued Nippon Shinyaku over Deramiocel distribution terms, citing pricing issues and patient access risks.read more...

Nasdaq, S&P 500 Futures Rise Ahead Of Jobs Report As Iran Ceasefire Holds: Why NVDA, IREN, CRWV, RKLB, UPWK, CAPR Are In Focus

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ this week.


CAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review

Capricor is seeking court approval to pursue an alternative commercialization path for Deramiocel and wants parts of the agreement terminated.

Capricor Therapeutics (CAPR) Projected to Post Earnings on Tuesday

Capricor Therapeutics (NASDAQ:CAPR) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...

Oppenheimer & Co. Inc. Cuts Stock Holdings in Capricor Therapeutics, Inc. $CAPR

Oppenheimer & Co. Inc. trimmed its position in shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) by 40.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 80,813 shares of the biotechnology company's stock after selling 54,600 s...

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAPRCapricor Therapeutics Inc

Fundamentals

Latest CAPR News